Nocutil (Desmopressin Acetate)

Desmopressin is a synthetic vasopressin analogue that selectively binds V2 receptors in the kidney, triggering aquaporin‑2 channel insertion and increasing water reabsorption. It also stimulates endothelial cells to release von Willebrand factor and factor VIII, enhancing primary hemostasis.

The appropriate dose of Nocutil is determined by the prescribing clinician based on the individual’s condition, age, renal function and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for desmopressin in pregnancy and lactation are limited. Clinicians weigh potential benefits against possible risks before prescribing. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To order Nocutil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Nocutil (desmopressin) is a selective V2‑receptor agonist, offering a more targeted antidiuretic effect than non‑selective agents such as carbamazepine. It also provides hemostatic benefits not seen with traditional diuretics, making it the preferred choice for conditions requiring both water retention and clotting support.

Nocutil should be stored at room temperature, below 25 °C, in its original packaging. Protect the nasal spray from moisture and direct sunlight to maintain potency and prevent degradation.

Nocutil is supplied as a metered‑dose nasal spray. The prescribed number of sprays is administered into one nostril, typically after priming the device. Patients should follow the exact dosing schedule provided by their prescriber and avoid sharing the spray.

The most serious risks include severe hyponatremia, which can lead to seizures, cerebral edema, or coma, and rare allergic reactions such as anaphylaxis. Prompt medical attention is required if symptoms like confusion, severe headache, vomiting, or rash develop.

Nocutil is contraindicated in patients with known hypersensitivity to desmopressin, uncontrolled hypertension, severe renal impairment, or those taking other antidiuretic agents that could precipitate dangerous hyponatremia. Clinicians should assess each patient’s medical history before prescribing.